Tachykinin neurokinin 3 receptor signaling in cholecystokinin-elicited release of oxytocin and vasopressin
Open Access
- 1 May 2008
- journal article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 294 (5) , R1760-R1767
Abstract
Neurokinin 3 receptor (NK3R) signaling has an integral role in the stimulated oxytocin (OT) and vasopressin (VP) release in response to hyperosmolarity and hypotension. Peripheral injections of cholecystokinin (CCK) receptor agonists for the CCK-A (sulfated CCK-8) and CCK-B (nonsulfated CCK-8) receptors elicit an OT release in rat. It is unknown whether NK3R contributes to this endocrine response. Freely behaving male rats were administered an intraventricular pretreatment of 250 or 500 pmol of SB-222200, a specific NK3R antagonist, or 0.15 M NaCl before an intraperitoneal or intravenous injection of CCK-8 (nonsulfated or sulfated) or 0.15 M NaCl. Blood samples were taken before intraventricular treatment and 15 min after intraperitoneal or intravenous injection, and plasma samples were assayed for OT and VP concentration. Intraperitoneal injection of both nonsulfated and sulfated CCK-8 significantly increased plasma OT levels and had no effect on plasma VP levels. Intravenous injection of sulfated CCK-8 stimulated an increase in plasma OT levels and did not alter plasma VP levels. However, intravenous injection of nonsulfated CCK-8 stimulated a significant increase in plasma levels of both OT and VP. No other studies have demonstrated CCK-8-stimulated release of VP in rat. NK3R antagonist did not alter baseline levels of either hormone. However, pretreatment of NK3R antagonist significantly blocked the CCK-stimulated release of OT in all CCK treatment groups and blocked VP release in response to intravenous injection of nonsulfated CCK-8. Therefore, central NK3R signaling is required for OT and VP release in response to CCK administration.Keywords
This publication has 66 references indexed in Scilit:
- Internuclear coupling of hypothalamic magnocellular nuclei by glutamate synaptic circuitsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2006
- Central neurokinin 3 receptors increase systemic oxytocin release: interaction with norepinephrineExperimental Neurology, 2003
- Presynaptic Noradrenergic Regulation of Glutamate Inputs to Hypothalamic Magnocellular NeuronesJournal of Neuroendocrinology, 2003
- Dose Response of Arginine Vasopressin to the CCK-B Agonist PentagastrinNeuropsychopharmacology, 2001
- Differential recruitment of hypothalamic neuroendocrine and ventrolateral medulla catecholamine cells by non-hypotensive and hypotensive hemorrhagesBrain Research, 1999
- Immunocytochemical localisation of NK3 receptors in the dorsal vagal complex of ratBrain Research, 1996
- Hypothalamic Histamine Release, Neuroendocrine and Cardiovascular Responses during Tuberomammillary Nucleus Stimulation in the Conscious RatNeuroendocrinology, 1993
- Distribution and origins of substance P-immunoreactive projections to the paraventricular and supraoptic nuclei: Partial overlap with ascending catecholaminergic projectionsJournal of Chemical Neuroanatomy, 1991
- Cholecystokinin evokes secretion of oxytocin and vasopressin from rat neural lobe independent of external calcium.Proceedings of the National Academy of Sciences, 1989
- Noradrenergic stimulation of supraoptic neuronal activity and vasopressin release in vitro: mediation by an α1-receptorBrain Research, 1986